HCRT and infarction: Furthermore, orexin-A significantly suppressed the development of infarction, increase of NDS score (neurological abnormalities) and decrease of latency by step-through test (memory disturbances) on day 3 after MCAO compared with the saline-treated group (Figure 1C–F).